In mouse models of lung cancer driven by L858R/T790M and L858R/T790M/C797S EGFR mutations, the tumour shrinks when treated synergistically with EAI045 and cetuximab, suggesting that EAI045 and cetuximab exhibit mechanistic synergy. The gene discussed is EGFR; the disease is lung carcinoma.